Adipose tissue deficiency, glucose intolerance, and increased atherosclerosis result from mutation in the mouse fatty liver dystrophy (fld) gene

Journal of Lipid Research

Volumn 41, Issue 7, 2000, Pages 1067-1076

  Reue, Karen ^a,b   Xu, Ping ^a,b   Wang, Xu Ping ^a   Slavin, Bernard G ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Gene expression; Insulin resistance; Lipodystrophy; Lipoproteins

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADIPSIN; FATTY ACID SYNTHASE; LIPOPROTEIN LIPASE;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; DYSTROPHY; FATTY LIVER; GENE ISOLATION; GENETIC SUSCEPTIBILITY; GLUCOSE INTOLERANCE; HISTOPATHOLOGY; INSULIN RESISTANCE; MOUSE; NEWBORN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ABNORMALITIES, MULTIPLE; ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; ARTERIOSCLEROSIS; BODY WEIGHT; FATTY LIVER; GENE EXPRESSION; GLUCOSE; GLUCOSE INTOLERANCE; HOMEOSTASIS; LIPODYSTROPHY; LIVER; MICE; MICE, MUTANT STRAINS; MUTATION; PHENOTYPE;

EID: 0033942169     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Sweet, H. O., E. H. Birkenmeier, and M. T. Davisson. 1988. Fatty liver dystrophy (fld). Mouse News Lett. 81: 69.
2. Langner, C. A., E. H. Birkenmeier, O. Ben-Zeev, M. C. Schotz, H. O. Sweet, M. T. Davisson, and J. I. Gordon. 1989. The fatty liver dystrophy (fld) mutation. A new mutant mouse with a developmental abnormality in triglyceride metabolism and associated tissue-specific defects in lipoprotein lipase and hepatic lipase activities. J. Biol. Chem. 264: 7994-8003.
3. Langner, C. A., E. H. Birkenmeier, K. A. Roth, R. T. Bronson, and J. I. Gordon. 1991. Characterization of the peripheral neuropathy in neonatal and adult mice that are homozygous for the fatty liver dystrophy (fld) mutation. J. Biol. Chem. 266: 11955-11964.
4. Reue, K., and M. H. Doolittle. 1996. Naturally occurring mutations in mice affecting lipid transport and metabolism. J. Lipid Res. 37: 1387-1405.
5. Rehnmark, S., C. S. Giometti, B. G. Slavin, M. H. Doolittle, and K. Reue. 1998. The fatty liver dystrophy mouse: microvesicular steatosis associated with reduced fatty acid oxidation and altered expression levels of peroxisome proliferator-regulated proteins. J. Lipid Res. 39: 2209-2217.
6. Rowe, L. B., H. O. Sweet, J. I. Gordon, and E. H. Birkenmeier. 1996. The fld mutation maps near to but distinct from the Apob locus on mouse chromosome 12. Mamm. Genome. 7: 555-557.
7. Klingenspor, M., P. Xu, R. D. Cohen, C. Welch, and K. Reue. 1999. Altered gene expression pattern in the fatty liver dystrophy mouse reveals impaired insulin-mediated cytoskeleton dynamics. J. Biol. Chem. 274: 23078-23084.
8. Cohen, R. D., L. W. Castellani, J-H. Qiao, B. J. Van Lenten, A. J. Lusis, and K. Reue. 1997. Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV. J. Clin. Invest. 99: 1906-1916.
9. Doolittle, M. H., O. Ben-Zeev, J. Elovson, D. C. Martin, and T. G. Kirchgessner. 1990. The response of lipoprotein lipase in feeding and fasting: evidence of post-translational regulation. J. Biol. Chem. 265: 4570-4577.
10. Reue, K., Y-R. Xia, V. W. Shi, R. D. Cohen, C. Welch, and A. J. Lusis. 1996. Localization of mouse peroxisome proliferator-activated receptor γ on chromosome 6. Mamm. Genome. 7: 390-391.
11. Spiegelman, B. M., M. Frank, and H. Green. 1983. Molecular cloning of mRNA from 3T3 adipocytes. Regulation of mRNA content for glycerophosphate dehydrogenase and other differentiation-dependent proteins during adipocyte development. J. Biol. Chem. 258: 10083-10089.
12. Holm, C., and T. Østerlund. 1999. Hormone-sensitive lipase and neutral cholesteryl ester lipase. In Lipase and Phospholipase Protocols. M. H. Doolittle and K. Reue, editors. Humana Press, Totowa. 109-121.
13. Hedrick, C. C., L. W. Castellani, C. H. Warden, D. L. Puppione, and A. J. Lusis. 1993. Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice. J. Biol. Chem. 268: 20676-20682.
14. Qiao, J. H., P. Z. Xie, M. C. Fishbein, J. Kreuzer, T. Drake, L. L. Demer, and A. J. Lusis. 1994. Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification. Arterioscler. Thromb. 14: 1480-1497.
15. West, D. B., C. N. Boozer, D. L. Moody, and R. L. Atkinson. 1992. Dietary obesity in nine inbred mouse strains. Am. J. Physiol. 262: R1025-R1032.
16. Klaus, S. 1997. Functional differentiation of white and brown adipocytes. BioEssays. 19: 215-223.
17. Ailhaud, G., P. Grimaldi, and R. Negrel. 1992. Cellular and molecular aspects of adipose tissue development. Annu. Rev. Nutr. 12: 207-233.
18. Cornelius, P., O. A. MacDougal, and M. D. Lane. 1994. Regulation of adipocyte development. Annu. Rev. Nutr. 14: 99-129.
19. Smas, C. M., and H. S. Sul. 1995. Control of adipocyte differentation. Biochem. J. 309: 697-710.
20. Weinstock, P. H., S. Levak-Frank, L. C. Hudgins, H. Radner, J. M. Friedman, R. Zechner, and J. L. Breslow. 1997. Lipoprotein lipase controls fatty acid entry into adipose tissue, but fat mass is preserved by endogenous synthesis in mice deficient in adipose tissue lipoprotein lipase. Proc. Natl. Acad. Sci. USA. 94: 10261-10266.
21. Ong, J. M., T. G. Kirchgessner, M. C. Schotz, and P. A. Kern. 1988. Insulin increases the synthetic rate and messenger RNA levels of lipoprotein lipase in isolated rat adipocytes. J. Biol. Chem. 263: 12933-12938.
22. Semenkovich, C. F., M. Wims, L. Noe, J. Etienne, and L. Chan. 1989. Insulin regulation of lipoprotein lipase activity in 3T3-L1 adipocytes is mediated at posttranscriptional and posttranslational levels. J. Biol. Chem. 264: 9030-9038.
23. Raynolds, M. V., P. D. Awald, D. F. Gordon, A. Gutierrez-Hartmann, D. C. Rule, W. M. Wood, and R. H. Eckel. 1990. Lipoprotein lipase gene expression in rat adipocytes is regulated by isoproterenol and insulin through different mechanisms. Mol. Endocrinol. 4: 1416-1422.
24. Foufelle, F., B. Gouhot, J. Pegorier, D. Perdereau, J. Girard, and P. Ferré. 1992. Glucose stimulation of lipogenic enzyme gene expression in cultured white adipose tissue - a role for glucose 6-phosphate. J. Biol. Chem. 267: 20543-20546.
25. DeFronzo, R. A. 1997. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis. Netherlands J. Med. 50: 191-197.
26. Pyorala, K., M. Laakso, and M. Uusitupa. 1987. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab. Rev. 3: 463-524.
27. Bierman, E. L. 1992. George Lyman Duff Memorial Lecture: Atherogenesis in diabetes. Arterioscler. Thromb. 12: 647-656.
28. Després, J-P., and A. Marette. 1994. Relation of components of insulin resistance syndrome to coronary disease risk. Curr. Opin. Lipidol. 5: 274-289.
29. Tontonoz, P., E. Hu, and B. M. Spiegelman. 1994. Stimulation of adipogenesis in fibroblasts by PPARγ-2, a lipid-activated transcription factor. Cell 79: 1147-1156.
30. Tontonoz, P., E. Hu, R. A. Graves, A. I. Budavari, and B. M. Spiegelman. 1994. mPPARγ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8: 1224-1234.
31. Tontonoz, R., E. Hu, J. Devine, E. G. Beale, and B. M. Spiegelman. 1994. PPARγ2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol. Cell. Biol. 15: 351-357.
32. Tanaka, T., N. Yoshida, T. Kishimoto, and S. Akira. 1997. Defective adipocyte differentiation in mice lacking the C/EBPβ and/or C/EBPδ gene. EMBO J. 16: 7432-7443.
33. DeFronzo, R. A. 1988. The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes. 37: 667-687.
34. Boden, G. 1999. Free fatty acids, insulin resistance, and type 2 diabetes mellitus. Proc. Assoc. Am. Physicians. 111: 241-248.
35. Brüning, J. C., M. D. Michael, J. N. Winnay, T. Hayashi, D. Hörsch, D. Accili, L. J. Goodyear, and C. R. Kahn. 1998. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell. 2: 559-569.
36. Paigen, B., B. Y. Ishida, J. Verstuyft, R. B. Winters, and D. Albee. 1990. Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. Arteriosclerosis. 10: 316-323.
37. Paigen, B., D. Mitchell, K. Reue, A. Morrow, A. J. Lusis, and R. C. LeBoeuf. 1987. Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. Proc. Natl. Acad. Sci. USA. 84: 3763-3767.
38. Kunjathoor, V. V., D. L. Wilson, and R. C. LeBoeuf. 1996. Increased atherosclerosis in streptozotocin-induced diabetic mice. J. Clin. Invest. 97: 1767-1773.
39. Semenkovich, C. F., and J. W. Heinecke. 1997. The mystery of diabetes and atherosclerosis. Time for a new plot. Diabetes. 46: 327-334.
40. Park, L., K. G. Raman, K. J. Lee, Y. Lu, L. J. Ferran, W. S. Chow, D. Stern, and A. M. Schmidt. 1998. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nature Med. 4: 1025-1031.
41. Vischer, U. M. 1999. Hyperglycemia and the pathogenesis of atherosclerosis: lessons from murine models. Eur. J. Endocrinol. 140: 1-3.
42. Senior, B., and S. S. Gellis. 1964. The syndrome of total lipodystrophy and partial lipodystrophy. Pediatrics. 33: 593-612.
43. Seip, M., and O. Trygstad. 1996. Generalized lipodystrophy, congenital and acquired (lipoatrophy). Acta Paediatr. Scand. Suppl. 413: 2-28.
44. Brunzell, J. D., S. W. Shankle, and J. E. Bethune. 1968. Congenital generalized lipodystrophy and systemic cystic angioniatosis: the simultaneous occurrence of two unusual syndromes in a single family. Ann. Intern. Med. 69: 501-516.
45. Dunnigan, M. G., M. Cochrane, A. Kelly, and J. W. Scott. 1974. Familial lipoatrophic diabetes with dominant transmission: a new syndrome. Q. J. Med. 43: 33-48.
46. Kobberling, J., and M. G. Dunnigan. 1986. Familial partial lipodystrophy: two types of an X linked dominant syndrome, lethal in the hemizygous state. J. Med. Genet. 23: 120-127.
47. Naito, C., and K. Togawa. 1974. A possible role of circulating lipoprotein triglycerides in the increase in concentration of free fatty acids and in insulin resistance in "total" lipodystrophy. J. Clin. Endocrinol. Metab. 39: 1030-1037.
48. Boucher, B. J., R. D. Cohen, M. W. France, and A. S. Mason. 1975. Plasma fatty acid turnover in total lipodystrophy. Clin. Endocrinol. 4: 83-88.
49. Adreelli, F., H. Hanaire-Broutin, M. Laville, J. P. Tauber, J. P. Riou, and C. Thivolet. 2000. Normal reproductive function in leptin-deficient patients with lipoatrophic diabetes. J. Clin. Endocrinol. Metab. 85: 715-719.
50. Dörfler, H., G. Rauh, and P. Bassermann. 1993. Lipoatrophic diabetes. Clin. Invest. 71: 264-269.
51. Sasaki, T., H. Ono, H. Nakajima, and J. Sugimoto. 1992. Lipoatrophic diabetes. J. Dermatol. 19: 246-249.
52. Tuck, R. R., J. G. McLeod, A. Basten, D. Ellis, and P. D. Kirwan. 1983. Total lipodystorphy - a report of a case with peripheral neuropathy and glomerulonehritis. Aust. N.Z. J. Med. 13: 65-69.
53. Ross, S. R., R. A. Graves, and B. M. Speigelman. 1993. Targeted expression of a toxin gene to adipose tissue: transgenic mice resistant to obesity. Genes Dev. 7: 1318-1324.
54. Wang, N. D., M. J. Finegold, A. Bradley, C. N. Ou, S. V. Abdelsayed, M. D. Wilde, L. R. Taylor, D. R. Wilson, and G. J. Darlington. 1995. Impaired energy homeostasis in C/EBP alpha knockout mice. Science. 269: 1108-1112.
55. Moitra, J., M. M. Mason, M. Olive, D. Krylov, O. Gavrilova, B. Marcus-Samuels, L. Feigenbaum, E. Lee, T. Aoyama, M. Eckhaus, M. L. Reitman, and C. Vinson. 1998. Life without white fat: a transgenic mouse, Genes Dev. 12: 3168-3181.
56. Shimomura, I., R. E. Hammer, J. A. Richardon, S. Ikemoto, Y. Bashmakov, J. L. Goldstein, and M. S. Brown. 1998. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes. Dev. 12: 3182-3194.
57. Shimomura, I., R. E. Hammer, S. Ikemoto, M. S. Brown, and J. L. Goldstein. 1999. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Science. 401: 73-76.
58. Cao, H., and R. A. Hegele. 2000. Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum. Molec. Genet. 9: 109-112.
59. Shackleton, S., D. J. Lloyd, S. N. Jackson, R. Evans, M. F. Niermeijer, B. M. Singh, H. Schmidt, G. Brabant, S. Kumar, P. N. Durrington, S. Gregory, S. O'Rahilly, and R. C. Trembath. 2000. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nature Genet. 24: 153-156.
60. Mu, J. L., J. K. Naggert, K. L. Svenson, G. B. Collin, J. H. Kim, C. McFarland, P. M. Nishina. D. M. Levine, K. J. Williams, and B. Paigen. 1999. Quantitative trait loci analysis for the differences in susceptibility to atherosclerosis and diabetes between inbred mouse strains C57BL/6J and C57BLKS/J. J. Lipid Res. 40: 1328-1335.
61. Péterfy, M., J. Phan, G. M. Oswell, P. Xu, and K. Reue. 1999. Genetic, physical and transcript map of the fld region on mouse chromosome 12. Genomics. 62: 436-444.